Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-dose 9-valent HPV Vaccine in Postpartum Women
NCT04274153Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Johns Hopkins University. Started Aug 2020; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT04274153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04274153.